A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity

Clinical trial NCT06974851 · RECRUITING

Trial details

NCT number: NCT06974851
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Bstructive Sleep Apnea (OSA) and Obesity

Start date: 2025-07-25
Primary completion: 2026-12-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.